Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer.

Murphy GJ, Holder JC.

Trends Pharmacol Sci. 2000 Dec;21(12):469-74. Review.

PMID:
11121836
2.

Experimental approaches to study PPAR gamma agonists as antidiabetic drugs.

Vázquez M, Silvestre JS, Prous JR.

Methods Find Exp Clin Pharmacol. 2002 Oct;24(8):515-23. Review.

PMID:
12500431
3.

Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?

Pershadsingh HA.

Expert Opin Investig Drugs. 2004 Mar;13(3):215-28. Review.

PMID:
15013941
4.
5.
6.

Biology and toxicology of PPARgamma ligands.

Tugwood JD, Montague CT.

Hum Exp Toxicol. 2002 Aug;21(8):429-37. Review.

PMID:
12412636
7.

Metabolic and additional vascular effects of thiazolidinediones.

Martens FM, Visseren FL, Lemay J, de Koning EJ, Rabelink TJ.

Drugs. 2002;62(10):1463-80. Review.

PMID:
12093315
8.

[Thiazolidinediones and PPARgamma system in repair of liver damage].

Marra F, Pastacaldi S.

Recenti Prog Med. 2002 Jan;93(1):9-15. Review. Italian.

PMID:
11851003
9.

[Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma)].

Dubois M, Vantyghem MC, Schoonjans K, Pattou F.

Ann Endocrinol (Paris). 2002 Dec;63(6 Pt 1):511-23. Review. French.

PMID:
12527853
10.

The mode of action of thiazolidinediones.

Hauner H.

Diabetes Metab Res Rev. 2002 Mar-Apr;18 Suppl 2:S10-5. Review.

PMID:
11921433
11.

Insulin resistance and its treatment by thiazolidinediones.

Lebovitz HE, Banerji MA.

Recent Prog Horm Res. 2001;56:265-94. Review.

PMID:
11237217
12.

[Evaluation of a thiazolidinedione compound as a new antidiabetic drug].

Toyota T.

Nihon Rinsho. 2001 Nov;59(11):2211-8. Review. Japanese.

PMID:
11712410
13.

Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome.

Miller AR, Etgen GJ.

Expert Opin Investig Drugs. 2003 Sep;12(9):1489-500. Review.

PMID:
12943493
14.
15.

Recent advances in peroxisome proliferator-activated receptor science.

Shearer BG, Hoekstra WJ.

Curr Med Chem. 2003 Feb;10(4):267-80. Review.

PMID:
12570700
16.

Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes.

Blaschke F, Caglayan E, Hsueh WA.

Endocrinol Metab Clin North Am. 2006 Sep;35(3):561-74, ix. Review.

PMID:
16959586
17.
18.

[Glitazones (thiazolidinedione)].

Ducobu J, Sternon J.

Rev Med Brux. 2000 Oct;21(5):441-6. Review. French.

PMID:
11109896
19.
20.

PPAR gamma/RXR as a molecular target for diabetes.

Lenhard JM.

Receptors Channels. 2001;7(4):249-58. Review.

PMID:
11697231
Items per page

Supplemental Content

Write to the Help Desk